Historical valuation data is not available at this time.
The Swiss Helvetia Fund Inc. (SWZ) is a non-diversified, closed-end investment company that primarily invests in Swiss equities. The fund seeks long-term capital appreciation through investments in Swiss companies, including small- and mid-cap stocks, which may offer growth potential not typically found in larger, more established firms. SWZ provides U.S. investors with exposure to the Swiss market, which is known for its stability, strong corporate governance, and globally competitive industries such as pharmaceuticals, banking, and manufacturing. The fund's competitive advantage lies in its focused approach to Swiss equities, managed by experienced investment professionals who leverage local market expertise.
The fund does not engage in direct R&D but invests in innovative Swiss companies, including those in healthcare and technology sectors.
SWZ offers U.S. investors targeted exposure to Swiss equities, benefiting from Switzerland's stable and innovative economy. However, the fund's performance is subject to currency risk, market volatility, and the closed-end structure, which may trade at premiums/discounts to NAV. Suitable for investors seeking international diversification with a focus on Switzerland.
SWZ Annual Report (SEC filings), Schroders Fund Overview, Bloomberg Terminal data.